The Emirates Drug Establishment acted against 71 unapproved peptide sellers, 14 of them influencers, as Dubai put clinic peptides under strict rules.
Recap by typeshit. Full story at WIRED Middle East.
Led by Alabama's Steve Marshall, the AGs call the supply chain a security risk and say an FDA import list could be used to launder knock-off semaglutide.
The FDA plan would let pharmacies compound peptides like BPC-157 under enforcement discretion, even though agency scientists say safety is unproven.
A man says Mounjaro and Trulicity caused his gastroparesis, and the clip walks through who must warn patients about side effects under Indiana law.
Alicia Butterfield claims Anthem denied her Zepbound once the drug got her below morbid obesity. A Los Angeles judge stayed her case pending arbitration.
Novo says results held across menopausal stages among 1,900 women, from 23.1% to 26.7%, against about 2% on placebo. The piece also pitches obesity ETFs.
Bauer, who has a PhD in neuroscience and endocrinology, joins Geller to discuss insulin resistance and the shame many women feel about their weight.
Loading…